These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35506336)

  • 1. Raman Spectroscopy Study of Skin Biopsies from Patients with Parkinson's Disease: Trends in Alpha-Synuclein Aggregation from the Amide I Region.
    León-Bejarano F; Méndez MO; Alba A; Rodríguez-Leyva I; González FJ; Rodríguez-Aranda MDC; Guevara E; Guirado-López RA; Ramírez-Elías MG
    Appl Spectrosc; 2022 Nov; 76(11):1317-1328. PubMed ID: 35506336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasensitive detection of aggregated α-synuclein using quiescent seed amplification assay for the diagnosis of Parkinson's disease.
    Mao H; Kuang Y; Feng D; Chen X; Lu L; Xia W; Gan T; Huang W; Guo W; Yi H; Yang Y; Wu Z; Dai W; Sun H; Wu J; Zhang R; Zhang S; Lin X; Yong Y; Yang X; Li H; Wu W; Huang X; Bian Z; Wong HLX; Wang XL; Poppell M; Ren Y; Liu C; Zou WQ; Chen S; Xu PY
    Transl Neurodegener; 2024 Jul; 13(1):35. PubMed ID: 39049095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raman spectroscopic characterization of secondary structure in natively unfolded proteins: alpha-synuclein.
    Maiti NC; Apetri MM; Zagorski MG; Carey PR; Anderson VE
    J Am Chem Soc; 2004 Mar; 126(8):2399-408. PubMed ID: 14982446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
    Poggiolini I; Erskine D; Vaikath NN; Ponraj J; Mansour S; Morris CM; El-Agnaf OMA
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34072869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural features of α-synuclein amyloid fibrils revealed by Raman spectroscopy.
    Flynn JD; McGlinchey RP; Walker RL; Lee JC
    J Biol Chem; 2018 Jan; 293(3):767-776. PubMed ID: 29191831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature.
    Schneider SA; Boettner M; Alexoudi A; Zorenkov D; Deuschl G; Wedel T
    Eur J Neurol; 2016 Feb; 23(2):247-61. PubMed ID: 26100920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives.
    Alzghool OM; van Dongen G; van de Giessen E; Schoonmade L; Beaino W
    Mov Disord; 2022 May; 37(5):936-948. PubMed ID: 35289424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of α-synuclein in vitro aggregation kinetics by its alternative splice isoforms.
    Röntgen A; Toprakcioglu Z; Tomkins JE; Vendruscolo M
    Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2313465121. PubMed ID: 38324572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies.
    Bargar C; Wang W; Gunzler SA; LeFevre A; Wang Z; Lerner AJ; Singh N; Tatsuoka C; Appleby B; Zhu X; Xu R; Haroutunian V; Zou WQ; Ma J; Chen SG
    Acta Neuropathol Commun; 2021 Apr; 9(1):62. PubMed ID: 33827706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.
    Singh SK; Dutta A; Modi G
    Future Med Chem; 2017 Jun; 9(10):1039-1053. PubMed ID: 28632413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease.
    Emmi A; Sandre M; Russo FP; Tombesi G; Garrì F; Campagnolo M; Carecchio M; Biundo R; Spolverato G; Macchi V; Savarino E; Farinati F; Parchi P; Porzionato A; Bubacco L; De Caro R; Kovacs GG; Antonini A
    Mov Disord; 2023 May; 38(5):885-894. PubMed ID: 36847308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration.
    Wang X; Becker K; Levine N; Zhang M; Lieberman AP; Moore DJ; Ma J
    Acta Neuropathol Commun; 2019 Mar; 7(1):41. PubMed ID: 30871620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
    Russo MJ; Orru CD; Concha-Marambio L; Giaisi S; Groveman BR; Farris CM; Holguin B; Hughson AG; LaFontant DE; Caspell-Garcia C; Coffey CS; Mollon J; Hutten SJ; Merchant K; Heym RG; Soto C; Caughey B; Kang UJ
    Acta Neuropathol Commun; 2021 Nov; 9(1):179. PubMed ID: 34742348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected Implication of SRP and AGO2 in Parkinson's Disease: Involvement in Alpha-Synuclein Biogenesis.
    Hernandez SM; Tikhonova EB; Baca KR; Zhao F; Zhu X; Karamyshev AL
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson's disease-related fibril polymorphism.
    Choong CJ; Aguirre C; Kakuda K; Beck G; Nakanishi H; Kimura Y; Shimma S; Nabekura K; Hideshima M; Doi J; Yamaguchi K; Nakajima K; Wadayama T; Hayakawa H; Baba K; Ogawa K; Takeuchi T; Badawy SMM; Murayama S; Nagano S; Goto Y; Miyanoiri Y; Nagai Y; Mochizuki H; Ikenaka K
    Acta Neuropathol; 2023 May; 145(5):573-595. PubMed ID: 36939875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
    Vilas D; Iranzo A; Tolosa E; Aldecoa I; Berenguer J; Vilaseca I; Martí C; Serradell M; Lomeña F; Alós L; Gaig C; Santamaria J; Gelpi E
    Lancet Neurol; 2016 Jun; 15(7):708-718. PubMed ID: 27039162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
    Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
    Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson's disease.
    Thomzig A; Wagenführ K; Pinder P; Joncic M; Schulz-Schaeffer WJ; Beekes M
    Acta Neuropathol; 2021 Jun; 141(6):861-879. PubMed ID: 33895878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gangliosides, α-Synuclein, and Parkinson's Disease.
    Ledeen RW; Wu G
    Prog Mol Biol Transl Sci; 2018; 156():435-454. PubMed ID: 29747823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.